Assessment of the Effect of Gluten Free Toothpaste on the Ulcerative Events in Children With Celiac Disease

July 18, 2020 updated by: Eman Adel Abd Elhameed, Cairo University

Assessment of the Effect of Gluten Free Toothpaste on the Ulcerative Events in Children With Celiac Disease (Before and After Pilot Study)

Celiac disease (CD) is the most common genetically based food intolerance in the world, with a prevalence among approximately 1% of the general population (Guandalini & Assiri, 2014). CD is a frequent disorder among Egyptian children, both in the general population and in at-risk groups(Abu-Zekry et al., 2008). It is estimated that the incidence of CD is 3 to13 cases per1000, with a higher prevalence among first-degree relatives of patients with CD.Lifelong adherence to a strict gluten free diet (GFD) remains the only available treatment for patients with CD and typically results in a complete return to health. Nevertheless, gluten is not found only in diet, Gluten is commonly used as a binder in products like medication, cosmetics, oral and skin care, and even children's toys. Gluten is found also in toothpastes and other oral health products and it can be swallowed by mistake and initiate immune response(Anon, n.d.). Unfortunately, there is no gluten free toothpaste available in the Egyptian market and it is very expensive if we bought it from Europe or USA. The tube will cost nearly 10 dolars .As a result, the production and availability of gluten free toothpaste in Egypt has become mandatory.

Study Overview

Status

Completed

Conditions

Detailed Description

production of an experimental gluten free toothpaste and providing it for children with celiac disease

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Al Manial, Cairo, Egypt
      • Giza, Al Manial, Cairo, Egypt, Egypt, 11562
        • Faculty of Dentistry, Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 13 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age above 6 yeas.
  2. Erupting lower 6.
  3. Can spit the toothpaste.
  4. Diagnosed as a celiac patient(pathology&serology)

Exclusion Criteria:

  1. With a history of allergy to any ingredient present in the toothpaste to be used for treatment
  2. The presence of serious medical conditions or a transmissible disease such as malignant disease, hepatitis, AIDS etc.
  3. Children whose parents had no home or mobile phone to enable post-operative contact.
  4. Parent that will not sign the consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: gluten free toothpaste
experimental gluten free toothpaste with natural ingredients prepared for the study to be used 3 times per day for six months
we prepared gluten free toothpaste in the faculty of pharmacy -Cairo university because there is no gluten free toothpaste available in the Egyptian market .
Other Names:
  • natural toothpaste

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ulcerative events
Time Frame: Six months
Reporting from the parent (Yes or No)
Six months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inflammation or ulceration
Time Frame: six months
visual (Yes or No)
six months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eman A Abdelhameed, BSc, Resident at pediatric Dentistry and Dental Public Health Department
  • Study Chair: Fatma KI Abdelgawad, PhD, Assistant Professor at Pediatric Dentistry and Dental Public Health Department
  • Study Director: Kamal M El Motayam, PhD, Emeritus Professor at Pediatric Dentistry and Dental Public Health Department

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 21, 2019

Primary Completion (Actual)

January 21, 2020

Study Completion (Actual)

January 21, 2020

Study Registration Dates

First Submitted

December 8, 2018

First Submitted That Met QC Criteria

December 8, 2018

First Posted (Actual)

December 11, 2018

Study Record Updates

Last Update Posted (Actual)

July 21, 2020

Last Update Submitted That Met QC Criteria

July 18, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gluten Sensitivity

Clinical Trials on experimental gluten free toothpaste

3
Subscribe